Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent (211)At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice

The α-emitter (211)At-labeled meta-astatobenzylguanidine ((211)At-MABG) has a strong antitumor effect on pheochromocytoma xenograft tumors and holds great promise as a new therapeutic option for malignant pheochromocytoma. To evaluate the acute radiation-related toxicity of (211)At-MABG, we conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudo, Hitomi, Tsuji, Atsushi B., Sugyo, Aya, Nagatsu, Kotaro, Minegishi, Katsuyuki, Ishioka, Noriko S., Ito, Hiroshi, Yoshinaga, Keiichiro, Higashi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514325/
https://www.ncbi.nlm.nih.gov/pubmed/31078058
http://dx.doi.org/10.1016/j.tranon.2019.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514325/
https://www.ncbi.nlm.nih.gov/pubmed/31078058
http://dx.doi.org/10.1016/j.tranon.2019.04.008

Ejemplares similares